SYNAURA
Synaura manufactures, supplies, and develops human milk oligosaccharides (HMO) for breastfed infants. The company specializes in biosynthesis technology and provides baby formula that has the same nutritional value as breast milk, allowing customers to use HMO products.
SYNAURA
Industry:
Health Care Medical Nutrition
Founded:
2022-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.synaura.cn
Status:
Active
Contact:
86-18753935700
Email Addresses:
[email protected]
Total Funding:
100 M CNY
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Google Maps Pound Sterling
Investors List
China Mengniu Dairy
China Mengniu Dairy investment in Seed Round - Synaura
Zhongjin Qide
Zhongjin Qide investment in Seed Round - Synaura
Kweichow Moutai
Kweichow Moutai investment in Seed Round - Synaura
CICC Qide
CICC Qide investment in Seed Round - Synaura
Official Site Inspections
http://www.synaura.cn
- Host name: 60.205.125.149
- IP address: 60.205.125.149
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Synaura"
SYNAURA
Synaura is an enterprise with advanced biosynthesis technology established in Pudong District, Shanghai. ... [email protected]; Links. Our Product; Product Applications; About Synaura; …See details»
Synaura - Crunchbase Company Profile & Funding
Contact Email [email protected]; Phone Number +86-18753935700; Synaura manufactures, supplies, and develops human milk oligosaccharides (HMO) for …See details»
Synaura 2025 Company Profile: Valuation, Funding & Investors
Synaura General Information Description. Manufacturer, provider and developer of human milk oligosaccharides (HMO) designed for breastfed babies. The company focuses on advanced …See details»
Synaura | 领英 - 领英 (中国)
Synaura | 在领英上有 57 位关注者。Your Partner in Technology and Nutrition. | Synaura is an enterprise with advanced biosynthesis technology established in Pudong District, Shanghai. …See details»
Synaura - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors ... Money Raised . Lead Investors . Oct 22, 2024: Series A - …See details»
虹摹生物-动脉网 - vbdata.cn
Feb 21, 2022 Synaura拥有10多个投资组合的愿景，涵盖生物医学、农业和健康食品等领域。 ... [email protected]. 虹摹生物2022年成立于上海张江，是一家拥有先进合成生物学技术的生物 …See details»
Simon Wang - Director of Worldwide Sales - Synaura | 领英
Director of Worldwide Sales - Synaura · Dynamic and results-driven professional with successful track records developing and implementing transformative sales strategies, managing global …See details»
About Synaura
Synaura is an enterprise with advanced biosynthesis technology established in Pudong District, Shanghai. ... [email protected]; Links. Our Product; Product Applications; About Synaura; Certificates & Honor; Contact; Other Link. China …See details»
Mengniu Driving Development of Innovative HMO Nutritional …
In August 2024, Synaura Biotechnology (Shanghai) Co., Ltd. (“Synaura”), a subsidiary of China Mengniu Dairy Company Limited (“Mengniu” or the “Company”), received GRAS certification …See details»
SYNAURA
Contact Info. SynauraBiotechnology (Shanghai) Co., Ltd. Building 2, Lane 500, FurongHua Road, Pudong New Area,Shanghai, CHINA; China Office：+86-13910088419See details»
虹摹生物科技（上海）有限公司 - 主要人员 - 爱企查
爱企查为您提供虹摹生物科技（上海）有限公司2025年主要人员信息查询，包括企业经理、执行董事、监事等企业人员信息查询，让您能够轻松快速了解公司主要人员信息，查询更多关于虹摹 …See details»
SYNAURA
In October 2023, Synaura 2 '- FL (2′-fucosyllactose) won the first batch of the Health Commission and became the only local approved enterprise in China. It has a new milestone significance in …See details»
虹摹生物（Synaura）完成新一轮融资 - 创投之家
May 9, 2024 虹摹生物（Synaura）是一家生物制造企业，由蒙牛集团与弈柯莱生物合资成立。去年，公司自主研发的HMO（母乳低聚糖）通过国家卫健委审批。 创投之 …See details»
China's Leading Domestic HMO Enterprise Synaura Completes
May 11, 2024 EqualOcean has learned that Synaura(虹摹生物)recently successfully completed a pre-Series A financing round of nearly CNY 100 million. This round of financing was led by …See details»
Hong G Biotechnology Shanghai Co. , Ltd. (Hong G Biotechnology …
了解Hong G Biotechnology Shanghai Co. , Ltd. (Hong G Biotechnology Shanghai Co. , Ltd.)公司的药物管线，治疗领域，技术平台，以及它的。See details»
Contact Info - synaura.cn
Contact Info. SynauraBiotechnology (Shanghai) Co., Ltd. Building 2, Lane 500, FurongHua Road, Pudong New Area,Shanghai, CHINA; China Office：+86-13910088419See details»
Mengniu Driving Development of Innovative HMO Nutritional …
Nov 26, 2024 HONG KONG SAR - Media OutReach Newswire - 26 November 2024 - In August 2024, Synaura Biotechnology (Shanghai) Co., Ltd. ("Synaura"), a subsidiary of China Mengniu …See details»
虹摹生物科技（上海）有限公司_投融资最新情况_摩熵医药 (原药融 …
Synaura拥有10多个投资组合的愿景，涵盖生物医学、农业和健康食品等领域。 洞察市场格局 解锁药品研发情报 免费客服电话. 18983288589. 试用企业版. 生物医药全产业链数据服务平台. 企 …See details»
【融资】虹摹生物（Synaura）完成新一轮融资医药新闻-ByDrug
⌈ByDrug医药新闻摘要⌋ 2024-05-09 17:02，微创投：虹摹生物科技（上海）有限公司（虹摹生物，Synaura）近日宣布完成新一轮融资，投资方为茅台科创（北京）投资基金合伙企业（有限 …See details»
SYNAURA
This innovative product specifically includes SynauraTMHMO, a breast milk oligosaccharide independently developed by Hongmu Biotechnology. This ingredient successfully passed the …See details»